Search

everythinglearnresearchcommunity

for

Search:↓

Trichoscopy is a quick, accurate, and non-invasive method to diagnose and treat non-scarring hair loss.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

Recognizing rare hair loss patterns in young females can improve understanding and treatment.

The research suggests that immune cells and a specific type of cell death called ferroptosis are involved in Frontal fibrosis alopecia.

Non-scarring hair loss is common in lupus patients and can be diagnosed with specific hair and tissue tests.

Brownish halos around axillary hair can help diagnose frontal fibrosing alopecia.

Alopecia areata causes sudden hair loss, has genetic links, and can be managed but not cured.

31% of female high school students in Minia have hair loss from tight hairstyles, which can become permanent if not treated early.

Alopecia, especially androgenic, may increase cardiovascular risk, but more research is needed.

Low-dose oral naltrexone may help reduce inflammation in some scarring alopecia patients.

Botulinum Toxin Type A delivered through the skin may be a promising treatment for Frontal Fibrosing Alopecia.

People with hair loss conditions often have more mental health issues like depression and anxiety compared to those without hair loss.

Women with frontal fibrosing alopecia have similar vitamin D levels to those with other hair loss types, suggesting vitamin D is not a key factor in this condition.

Accurate diagnosis and understanding of alopecia areata in children are crucial for proper treatment.

A woman thought to have rosacea was actually suffering from Frontal Fibrosing Alopecia, a hair loss condition. Despite treatment, her condition didn't change, showing the importance of accurate early diagnosis.

The research found that certain characteristics like age, sex, race, marital status, and education level can influence whether alopecia patients stick to their hair loss treatment with topical minoxidil.

Some hair loss disorders cause permanent loss due to scarring, and treatments like steroids don't always work well.

Treatment improved some symptoms but not all.

The document concludes that non-scarring alopecias can be reversed, but scarring alopecias cause permanent hair loss.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition with inflammation and scarring, resembling but distinct from common balding.

Autoimmune and inflammatory processes are involved in both scarring and non-scarring types of hair loss.

Protein profiling of forehead skin can help distinguish between frontal fibrosing alopecia and androgenetic alopecia.

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

Apoptosis contributes to hair loss in androgenetic alopecia.

Trichoscopy helps diagnose hairline recession causes in Egyptian women, with androgenetic alopecia being the most common.

The paper concludes that recognizing bitemporal alopecia areata is important for early treatment and preventing its progression.

Oral minoxidil can potentially increase hair growth in people suffering from Central Centrifugal Cicatricial Alopecia.

Frontal fibrosing alopecia mainly affects women over 50, causing hair loss and specific skin changes.

Transplanted hair follicles can resist hair loss from an autoimmune condition better than natural hair.

Some people with pattern hair loss may also have scalp inflammation and scarring similar to lichen planopilaris.